ATE349530T1 - Nukleinsäuren und proteine des mph3 gens aus mycoplasma hypopneumoniae und deren verwendung - Google Patents

Nukleinsäuren und proteine des mph3 gens aus mycoplasma hypopneumoniae und deren verwendung

Info

Publication number
ATE349530T1
ATE349530T1 AT01303030T AT01303030T ATE349530T1 AT E349530 T1 ATE349530 T1 AT E349530T1 AT 01303030 T AT01303030 T AT 01303030T AT 01303030 T AT01303030 T AT 01303030T AT E349530 T1 ATE349530 T1 AT E349530T1
Authority
AT
Austria
Prior art keywords
nucleic acids
proteins
mph3
gene
mycoplasma
Prior art date
Application number
AT01303030T
Other languages
English (en)
Inventor
Kendall Wayne King
Rebecca Anne Madura
Everett Lee Rosey
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE349530T1 publication Critical patent/ATE349530T1/de

Links

Classifications

    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02K—DYNAMO-ELECTRIC MACHINES
    • H02K37/00—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors
    • H02K37/10—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors of permanent magnet type
    • H02K37/12—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors of permanent magnet type with stationary armatures and rotating magnets
    • H02K37/14—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors of permanent magnet type with stationary armatures and rotating magnets with magnets rotating within the armatures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Power Engineering (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01303030T 2001-03-28 2001-03-30 Nukleinsäuren und proteine des mph3 gens aus mycoplasma hypopneumoniae und deren verwendung ATE349530T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002340455A CA2340455A1 (en) 2001-03-28 2001-03-28 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
JP2001101364A JP2002306169A (ja) 2001-03-28 2001-03-30 マイコプラズマ属のＭｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅのｍｈｐ３遺伝子の核酸およびタンパク質ならびにそれらの使用
EP01303030A EP1245677B1 (de) 2001-03-28 2001-03-30 Nukleinsäuren und Proteine des mph3 Gens aus Mycoplasma hypopneumoniae und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE349530T1 true ATE349530T1 (de) 2007-01-15

Family

ID=27171482

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01303030T ATE349530T1 (de) 2001-03-28 2001-03-30 Nukleinsäuren und proteine des mph3 gens aus mycoplasma hypopneumoniae und deren verwendung

Country Status (8)

Country Link
EP (1) EP1245677B1 (de)
JP (1) JP2002306169A (de)
AT (1) ATE349530T1 (de)
CA (1) CA2340455A1 (de)
CY (1) CY1105947T1 (de)
DE (1) DE60125507T2 (de)
DK (1) DK1245677T3 (de)
ES (1) ES2277893T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101952332B1 (ko) 2009-12-04 2019-02-26 가부시키가이샤 엘에스아이 메디엔스 마이코플라즈마·뉴모니에 및/또는 마이코플라즈마·제니탈륨에 속하는 미생물을 검출하는 방법
CN105792841B (zh) * 2013-11-21 2019-07-26 财团法人农业科技研究院 防治霉浆菌感染的组合物
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
CN106928373B (zh) * 2017-03-17 2020-08-28 青岛明勤生物科技有限公司 一种猪支原体肺炎多表位黏膜疫苗
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252328A (en) * 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof

Also Published As

Publication number Publication date
DK1245677T3 (da) 2007-04-02
DE60125507D1 (de) 2007-02-08
EP1245677B1 (de) 2006-12-27
CA2340455A1 (en) 2002-09-28
CY1105947T1 (el) 2011-04-06
EP1245677A1 (de) 2002-10-02
JP2002306169A (ja) 2002-10-22
DE60125507T2 (de) 2007-10-04
ES2277893T3 (es) 2007-08-01

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
NO20033364D0 (no) Fremgangsmåte for identifikasjon, isolasjon og produksjon av antigener tilet spesifikt patogen
WO2005063820A3 (en) Il-7 fusion proteins
DE69938302D1 (de) Neisseria meningitidis antigene und zusammenstellungen
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
NO20025838L (no) Antigeniske polypeptider
DK1446162T3 (da) Kombinationsmotiv-immunstimulatoriske oligonukleotider med forbedret aktivitet
ATE375391T1 (de) Chlamydia-antigene und entsprechende dna- fragmente und deren verwendungen
ATE414104T1 (de) Fragmente des menschlichen choriogonadotropin (hcg) als immunregulator
DE69935986D1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
DE60045721D1 (de) Streptococcus pneumoniae Proteine und Impfstoffe
ATE546153T1 (de) Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen
CY1105947T1 (el) Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
BR0315042A (pt) Terapia para o tratamento de aterosclerose baseada em imunização passiva por peptìdeo
ATE382056T1 (de) Virulenz gene, proteine, und ihre verwendung
DE60226612D1 (de) Autologe t-zell-vakzinmaterialien und verfahren
EP1090995A3 (de) Mycoplasma hyopneumoniae Antigen MHP3, dafür kodierendes Gen und Ihre Verwendungen
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
ATE466086T1 (de) Expec-spezifische proteine, entsprechende gene und ihre verwendungen
ATE513044T1 (de) Nukleotid und aminosäuresequenzen aus photobacterium damselae und deren verwendung
BR0308180A (pt) protéinas de superfìcie de leptospira
AR027745A1 (es) Acidos nucleicos y proteinas del gen mhp3 de mycoplasma hyopneumoniae y sus usos
WO2002044366A3 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
ATE515270T1 (de) Phep, eine aminosäurepermease von staphylococcus aureus
ATE464065T1 (de) Neue medizinische verwendung von alpha-antigen oder alpha-antigen-gen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1245677

Country of ref document: EP